about
MiR-592 functions as a tumor suppressor in glioma by targeting IGFBP2.MiR-186 Inhibited Migration of NSCLC via Targeting cdc42 and Effecting EMT Process.MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.Block copolymer conjugated Au-coated Fe3O4 nanoparticles as vectors for enhancing colloidal stability and cellular uptake.MicroRNA-107-5p suppresses non-small cell lung cancer by directly targeting oncogene epidermal growth factor receptor.Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.Therapeutic targeting of non-coding RNAs in cancer.Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST.MicroRNA-664a-5p promotes neuronal differentiation of SH-SY5Y cells.Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.In vitro transfection of anti-tumor miR-101 induces BIM, a pro-apoptotic protein, expression in acute myeloid leukemia (AML).Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer.MicroRNA-145 regulates the proliferation, migration and invasion of human primary colon adenocarcinoma cells by targeting MAPK1Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 CasesInhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathway
P2860
Q38696999-D495299F-9EF8-4779-8A58-3BD1EA94F3EEQ38711597-AC2AB013-A8FC-4464-89C6-20941ADD6E19Q41082747-546DA261-853F-46B9-8543-3CE5380DF137Q41117115-900F6D15-0326-40CA-8652-0E174CD9A48BQ41343483-B9D6EB52-BC35-42DA-94BE-A1C802894CA2Q41396184-CF54C06D-987C-43E6-A0A7-FD23540EC1B2Q47292099-5134C2F3-03CC-414F-A329-B442E0DE2072Q48132734-04EE0F75-9B9D-41F8-9DC2-EFC90C9AE5EFQ48227803-A44869C4-2BB8-4A45-8C5D-7477A1893510Q49375967-A1DDEC9A-9E7E-461D-9D55-DEB3E31C5696Q49642332-037E2A54-4254-48F4-9509-2B94D76269CDQ50131778-83138538-82C5-4AF6-A198-AC40CD2B9084Q50884607-F0E7AC15-E9DB-4FCD-925E-D1232D48DA6BQ55282272-5CE922BA-8A6D-4381-8457-404015BF0F40Q57056132-37A37DE8-90B0-41D4-8ECB-40E99F0405F5Q57109618-1F164CFB-223E-4481-B32D-DDAD736AE1F6Q58565330-ADCBA4B0-5AE6-4DA5-8FFA-8A3DA7E0F708
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting MicroRNAs in Cancer Gene Therapy.
@en
Targeting MicroRNAs in Cancer Gene Therapy.
@nl
type
label
Targeting MicroRNAs in Cancer Gene Therapy.
@en
Targeting MicroRNAs in Cancer Gene Therapy.
@nl
prefLabel
Targeting MicroRNAs in Cancer Gene Therapy.
@en
Targeting MicroRNAs in Cancer Gene Therapy.
@nl
P2860
P356
P1433
P1476
Targeting MicroRNAs in Cancer Gene Therapy.
@en
P2093
P2860
P356
10.3390/GENES8010021
P50
P577
2017-01-09T00:00:00Z